L’Oréal announced the winners of its International Awards for Social Responsibility in Dermatology, “Caring to Inspire Skin Confidence” at the 23rd World Congress of Dermatology taking place in Vancouver, Canada.
Dr. Ksenia Sorokina from Russia
A healthy child means a healthy family- Targeting prevention of dermatitis and adherence to treatment
This project consists of providing training workshops for parents and children with chronic skin diseases and developing the first ever website to allow patients living in remote areas of the Russian Federation to access a consultation with a dermatologist, as well as attend online training seminars for people presenting chronic dermatitis and to increase adherence to therapy for patients as well as their parents, within four Russian territories.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7554651-loreal-announces-2015-awardees/
SC Johnson, the world's leading manufacturer of pest control products, is using its 60 years of insect expertise to educate consumers as the Zika virus continues to spread. Immediately following the initial outbreak in Brazil, the company assembled its experts and began developing educational resources for consumers to understand how to best protect themselves against mosquitoes that may carry disease.
In addition to educating consumers, SC Johnson is actively working with organizations around the world to donate and distribute product to those in need. In coordination with the U.S. Centers for Disease Control and Prevention (CDC) Foundation, SC Johnson supported the Zika Action Plan Summit held by the White House and the CDC on April 1, and also donated to the CDC's Zika Prevention Kits. Additional donations have been made to AmeriCares, the Rio de Janeiro-based Children’s Health Association and the County of Hawaii Civil Defense Agency.
For nearly 60 years, SC Johnson entomologists have studied insects at the Entomology Research Center in Racine, Wis., the world's largest private, urban entomology research center. In their research, they help SC Johnson create products that consumers can trust and to provide them with the right product for their pest control needs. SC Johnson is the world's largest manufacturer of insect repellent and household insecticides, including OFF!®, Raid®, Autan® and Baygon®.
To view the multimedia release go to:
http://www.multivu.com/players/English/7787731-sc-johnson-zika-mosquito-protection/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
Syneron Medical Ltd., the leading global aesthetic device company, announced to a group of international media its new activities and enhanced global commitment to developing the non-invasive body shaping market, one of the fastest growing segments in the global aesthetic medical device market. The press conference took place at the Academy of Medical Sciences in London, just prior to the opening of the BODY Conference and Exhibition, which took place in London on November 3-4, 2012 and for which Syneron was the main sponsor.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58631-body-shaping-by-syneron
If diagnosed early enough 90% of melanoma cases can be treated effectively. An exclusive study carried out by Ipsos for La Roche-Posay in 23 countries across all continents looks into the different attitudes to the sun and general knowledge of the risks associated with exposure. A massive 88% of those questioned are aware of the risks of developing skin cancer when exposed without protection to the sun. However, just 1 in 2 of those questioned have ever consulted a dermatologist for a mole screening and 1 in 4 of them have never even checked their own moles on their body.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7438251-la-roche-posay-become-skin-checker/
With 830 women dying every day from preventable causes related to pregnancy and childbirth, and over 16,000 children under age five dying daily, Bayer and the White Ribbon Alliance today released critical policy recommendations and launched community programs to support the reduction and prevention of maternal, newborn and child mortality in two developing countries.1,2
Established through a three-year $1.3 million commitment from Bayer, these programs will expand work conducted by White Ribbon Alliance in Bangladesh and Zimbabwe to support the United Nations Secretary General’s Every Woman Every Child movement.
This announcement comes at the one-year anniversary of the Bayer/White Ribbon Alliance commitment in support of the Every Woman Every Child movement and will contribute to the success of the Sustainable Development Goals.
To view the multimedia release go to:
http://www.multivu.com/players/English/77126510-bayer-white-ribbon-alliance-self-care/
Global demand for food has never been higher, as populations skyrocket and developing areas of the world strive to feed their citizens. But in the United States, more than one–third of the food produced is never eaten and a new online survey of U.S. grocery shoppers’ attitudes conducted by Harris Poll on behalf of Sealed Air Corporation (NYSE: SEE) shows that food waste in the U.S. is near the top of the list of consumers’ environmental concerns and they are willing to change behaviors if better informed on the issue. The April 2014 study interviewed over 1,000 U.S. adults (aged 18+) who do at least 25% of their household’s grocery shopping (“American grocery shoppers”).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7270651-sealed-air-2014-food-waste-survey/
The Investor Desk Presents US Highland, Inc. (OTC PINK: UHLN), a diversified product development, sales, and marketing company.
Since its founding in 1997 as Highland AB in Sweden, the Texas-based company has been developing and manufacturing high-performance single cylinder and V-twin powertrains used for a variety of applications. In September 2015, the publicly traded company began diversifying its operations, guiding startups in the marketing, reselling, and distributing of their products, as well as helping customers establish their brand and penetrate the U.S. market.
Overseeing the company’s growth is chief executive officer and president Josh Whitaker, a marketing executive with global experience in technology marketing, strategy, and implementation. Whitaker has worked with high-profile brands like Red Bull and Under Armour, as well as industry leading companies like Tucker Rocky Distributing and KTM Motorcycles.
Over the past two decades, US Highland, Inc. has tapped a variety of distribution channels, enabling growing businesses, both domestic and foreign, to launch their products in the United States whether wholesale, retail, or over the Internet.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7660851-us-highland-the-investor-desks-new-company/
Vestergaard, a global company dedicated to improving the health of disadvantaged people, launched its LifeStraw® Follow the Liters program in Kenya this month. As part of this program, high-volume LifeStraw® Community water purifiers have been distributed to provide more than 23 million liters of safe water a year to over 125,000 school children throughout Kenya’s western province.
The distribution is made possible through the LifeStraw® Follow the Liters program which harnesses the collective power of individuals to help solve one of the world’s most pressing issues – lack of access to safe drinking water for people in developing countries. When a consumer purchases any LifeStraw® product, a portion of the funds are used to provide one school child in a developing country with safe drinking water for an entire school year.
To view the Multimedia News Release, go http://www.multivu.com/players/English/7351651-vestergaard-lifestraw-follow-the-liters-program-kenya-safe-water/
High-powered research teams supported by the Crohn's & Colitis Foundation of America (CCFA) are gearing up for an ambitious new goal: developing individualized treatment approaches for patients with Crohn's disease and ulcerative colitis (UC), also known as inflammatory bowel diseases (IBD), through their Genetics and Microbiome Research Initiatives.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/65964-ccfa-genetic-microbiome-discoveries-ibd-crohn-s-disease-ulcerative-colitis
As America takes steps to improve our energy security, home-grown fuel sources are more important that ever. One of the fuel sources of the future is algae, small aquatic organisms that convert sunlight into energy and store it in the form of oil. Scientists and engineers at the Energy Department and its national laboratories are researching the best strains of algae and developing the most efficient farming practices. This edition of Energy 101 shows how oil is extracted from algae and refined into sustainable biofuels.
For more information on biofuels visit http://www.eere.energy.gov.
Chiasma, Inc., a U.S. privately–held biopharma company developing octreotide capsules for the orphan condition acromegaly, today announced two new studies presented at the 97th Endocrine Society (ENDO) Annual Meeting in San Diego, Calif. The studies provide additional data from Chiasma’s Phase III trial and new findings on the patient burden of current injection therapies.
“We now have data to help clinicians determine whether octreotide capsules, if approved, are likely to help their patient with acromegaly maintain response,” said Shlomo Melmed, M.D., senior vice president and dean, Cedars–Sinai Medical Center, Los Angeles and global study principal investigator. “Furthermore, the Phase III results show the safety and efficacy of octreotide capsules can be reliably determined within 12 weeks of initiating therapy.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7436451-endo-chiasma-clinical-data/
